Stay updated on BTD-001 in IH & Narcolepsy Type 2 Clinical Trial
Sign up to get notified when there's something new on the BTD-001 in IH & Narcolepsy Type 2 Clinical Trial page.

Latest updates to the BTD-001 in IH & Narcolepsy Type 2 Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference5%
- Check21 days agoChange DetectedThe page has been updated to version v3.1.0 and several related topics (MedlinePlus topics on drug safety and counterfeit/substandard drugs) have been removed. Overall, this is a minor, metadata-level update with no new core content or time-sensitive information added.SummaryDifference0.8%
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedUpdated to Revision: v3.0.2 (from v3.0.1); the 'Back to Top' element was removed.SummaryDifference0.3%
- Check43 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.3%
- Check50 days agoChange DetectedThe web page has updated its facility information by adding new resources related to idiopathic hypersomnia and drug safety, while removing previous references to narcolepsy and cataplexy.SummaryDifference4%
- Check64 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.1%
Stay in the know with updates to BTD-001 in IH & Narcolepsy Type 2 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BTD-001 in IH & Narcolepsy Type 2 Clinical Trial page.